Wedbush Securities’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-5,902
| Closed | -$238K | – | 1241 |
|
2024
Q2 | $238K | Buy |
+5,902
| New | +$238K | 0.01% | 984 |
|
2020
Q4 | – | Sell |
-2,563
| Closed | -$291K | – | 971 |
|
2020
Q3 | $291K | Buy |
+2,563
| New | +$291K | 0.03% | 630 |
|
2020
Q1 | – | Sell |
-4,889
| Closed | -$291K | – | 1005 |
|
2019
Q4 | $291K | Sell |
4,889
-1,197
| -20% | -$71.2K | 0.03% | 691 |
|
2019
Q3 | $359K | Sell |
6,086
-1,678
| -22% | -$99K | 0.04% | 565 |
|
2019
Q2 | $501K | Sell |
7,764
-280
| -3% | -$18.1K | 0.05% | 437 |
|
2019
Q1 | $511K | Sell |
8,044
-3,344
| -29% | -$212K | 0.05% | 399 |
|
2018
Q4 | $432K | Sell |
11,388
-1,686
| -13% | -$64K | 0.06% | 401 |
|
2018
Q3 | $560K | Sell |
13,074
-10,253
| -44% | -$439K | 0.06% | 353 |
|
2018
Q2 | $514K | Sell |
23,327
-9,097
| -28% | -$200K | 0.06% | 371 |
|
2018
Q1 | $161K | Buy |
32,424
+2,915
| +10% | +$14.5K | 0.02% | 714 |
|
2017
Q4 | $70K | Buy |
29,509
+10,621
| +56% | +$25.2K | 0.01% | 810 |
|
2017
Q3 | $138K | Buy |
18,888
+8,871
| +89% | +$64.8K | 0.02% | 757 |
|
2017
Q2 | $80K | Buy |
10,017
+1,833
| +22% | +$14.6K | 0.01% | 782 |
|
2017
Q1 | $98K | Buy |
8,184
+450
| +6% | +$5.39K | 0.01% | 775 |
|
2016
Q4 | $166K | Buy |
7,734
+3,807
| +97% | +$81.7K | 0.02% | 691 |
|
2016
Q3 | $301K | Buy |
+3,927
| New | +$301K | 0.04% | 514 |
|